A large-scale genome study uncovered IL31 as a key genetic contributor to prurigo nodularis, linking it to immune-regulatory ...

Nemolizumab significantly and safely improved itch and skin lesions for up to 2 years in patients with moderate to severe prurigo nodularis.

The Business Research Company's Key Trend Shaping The Nodular Prurigo Market In 2025: Regulatory Approvals Driving Innovation In The Market It will grow to $3.06 billion in 2029 at a compound ...

Pulmonary rheumatoid nodules can resemble cancer or infection, making biopsy and careful imaging critical for accurate diagnosis.

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, according to results from a long-term extension ...

Subjects in the trial saw clearance or near-clearance of skin nodules, as measured by the Investigator’s Global Assessment score.

FDA approves first targeted therapy for bullous pemphigoid (BP): Dupixent (dupilumab) becomes the first and only targeted treatment approved for adults with this rare autoimmune blistering disease.

Scratching also causes undesirable changes in skin such as lichenification and prurigo nodule formation. Successful treatment of itch requires interruption of this cycle.

A former White House ethics lawyer who has been a persistent thorn in the side of Donald Trump is actually celebrating parts of the Supreme Court's recent rulings widely seen as favorable to the ...